Community Paramedicine at Home (CP@Home)
Community Paramedicine at Home (CP @Home)
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Ontario
-
Hamilton、Ontario、カナダ、L8S4K1
- McMaster University
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- 3 or more EMS calls in the last 6 months from intervention start date AND active caller in the last 30 days OR
- Any call for a lift assist to EMS in the past 30 days OR
- Paramedic referral into program (identified by paramedic through usual practice)
Exclusion Criteria:
- Individuals living in long term care facilities
- Individuals currently involved in a home visit or social navigator program
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：単一グループの割り当て
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし：コントロール
いつものお手入れ
|
|
|
実験的：CP@Home Intervention
The experimental group will receive the CP@Home program. The main elements of this program include BP assessment, diabetes risk assessment, falls risk assessment, heart failure risk assessment, neurologic assessment, psychiatric assessment, depression screening, health-related quality of life analysis (including pain, mobility, anxiety/depression, ADLs), social isolation screening, and food and income security. The program is targeted at referrals to appropriate community resources, identification and referral of high-risk patients to their family physician (FP), as well as regular communication of participants' health information to their physician. The intervention will be implemented by community paramedics from the local paramedic service who have undergone a structured training program (4 hours of online, interactive training modules, including case studies and the observation of an intervention visits led by another paramedic) to assure intervention fidelity. |
Community paramedics (CPs) will be assigned to visiting the participants for a first time the week following the initial EMS call.
Participants will complete the informed consent process with a CP on their first visit.
This visit will also include a full assessment and risk analysis that will take approximately 90 minutes and will be located in the participant's home.
As a result of the initial visit, the CP will make all relevant clinical referrals and decisions based on predetermined @Home algorithms.
A second visit will be made to the participant 2-4 weeks following the initial call for a streamlined follow-up and reassessment during a 30 minute period.
A final visit will be made 6-8 weeks following the initial call for a final evaluation of their situation.
It is anticipated the patient will be discharged from the CP@Home program at this point.
If the patient calls EMS following the third visit, if they meet the inclusion criteria, they will be re-entered into the CP@Home program.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in number of repeat EMS calls
時間枠：Baseline and 1 year
|
Individual-level change in EMS call rate resulting in ambulance dispatch (pre-post intervention)
|
Baseline and 1 year
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in number of ED presentations
時間枠：Baseline and 1 year
|
Individual-level change in number of ED presentations (pre-post)
|
Baseline and 1 year
|
|
Change in number of hospital admissions
時間枠：Baseline and 1 year
|
Individual-level change in number of hospital admissions (pre-post)
|
Baseline and 1 year
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Gina Agarwal, MBBS MRCGP CCFP PhD、McMaster University
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。